Scribeberry vs Tali AI
The Canadian shortlist, and it is a genuinely close one because both hold the certification position most of this category lacks. Both are SOC 2 Type II, both claim PHIPA, PIPEDA and HIPAA, and both were vetted through Canadian public procurement, Scribeberry through Supply Ontario and Tali through the Canada Health Infoway scribe programme. Tali is the deeper integration play, with effectively complete coverage of the Canadian record system market and both notes and recordings stored and processed inside Canada. Scribeberry is the broader and more commercially open one, publishing 99 US dollars per provider per month with every integration included, claiming more than 90 specialties, documenting in English and French, and enforcing dual residency so Canadian data stays in Canada and United States data in the United States. If your record system is on Tali's list, Tali. If you practise across both countries or need French, Scribeberry.
- Regulatory coverage that names the statutes a Canadian buyer is actually governed by, spanning HIPAA, PIPEDA, PHIPA and Quebec Law 25, the last of which almost nobody else names, with business associate agreements signed.
- Published pricing that is simple and inclusive, 99 US dollars per provider per month for unlimited use with every integration included and no per feature or per connection charge, stated on the site rather than behind a quote.
- Breadth on both coverage and residency: more than 90 specialties claimed with named coverage from family medicine to dentistry, documentation in English and French, and enforced regional residency keeping Canadian data in Canada and United States data in the United States.
- Effectively complete coverage of one national record system market, with integrations spanning Accuro, TELUS Collaborative Health Record, Med Access, Oscar Pro, PS Suite and more, which is a harder achievement than partial coverage of several.
- Both notes and recordings are stored and processed within Canada, a stronger statement than the note only residency commitments common in this category, with configurable residency options for buyers who need them.
- A deliberate insert step rather than an automatic write: the note is generated and edited inside Tali, and only then does the clinician choose to place it in the chart, which separates generation from the record by design.
Side by Side
| Axis | S Scribeberry |
T Tali AI |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Ambient Scribes page.
Both vendors publish accuracy or speed claims that cannot be checked. Scribeberry claims 99.9 percent accuracy with no methodology, reference standard, denominator or date, and Tali offers speed rather than correctness, describing documentation three times faster than typing. Neither names a model, publishes an evaluation method or publishes an accent, dialect or language performance analysis, which matters in a bilingual market.
Scribeberry's ADA autonomous intake agent is a materially different risk surface from the scribe and should be evaluated separately rather than assumed to inherit the scribe's oversight model. Neither vendor has a peer reviewed study or controlled evaluation; their external reference points are procurement vetting rather than clinical evidence.